Inventor · disambiguated record
Dorla Mirejovsky
Also filed as: MIREJOVSKY DORLA
9 granted patents·5 pending applications·168 citations·filing 1984–2023
88Inventor score
Files withBELOTECA INC3GENSIA SICOR PHARMACEUTICALS I3MIREJOVSKY DORLA2ALLERGAN INC1ALLERGAN PHARMA1
Top patents by PatentIndex Score
14 records- 0187US6469069B1Propofol composition containing sulfiteGENSIA SICOR PHARMACEUTICALS I·Filed 2000·Granted Oct 22, 2002·55 cites·27 claims
- 0282US8563592B2Bladder cancer treatment and methodsNUIJEN BASTIAAN·Filed 2011·Granted Oct 22, 2013·3 cites·12 claims
- 0378US9295666B2Bladder cancer treatment and methodsSPECTRUM PHARMACEUTICALS INC·Filed 2013·Granted Mar 29, 2016·1 cites·12 claims
- 0478US6147122APropofol composition containing sulfiteGENSIA SINCOR INC·Filed 1999·Granted Nov 14, 2000·58 cites·80 claims
- 0570US7153840B2Aqueous fludarabine phosphate compositionSICOR INC·Filed 2003·Granted Dec 26, 2006·2 cites·25 claims
- 0670US6709674B2Injectable pamidronate disodiumGENSIA SICOR PHARMACEUTICALS I·Filed 2002·Granted Mar 23, 2004·3 cites·19 claims
- 0769US4743588ACompositions and methods of enhancing transdermal and transmembrane penetration systemic agentsALLERGAN PHARMA·Filed 1984·Granted May 10, 1988·28 cites·12 claims
- 0863US6906047B2Aqueous ifosfamide compositionGENSIA SICOR PHARMACEUTICALS I·Filed 2002·Granted Jun 14, 2005·1 cites·20 claims
- 0962US2009163570A1Bladder cancer treatment and methodsMIREJOVSKY DORLA·Filed 2009·Application pending·0 cites
- 1056US2007185188A1Bladder cancer treatment and methodsMIREJOVSKY DORLA·Filed 2007·Application pending·0 cites
- 1156US2025049709A1Ziprasidone formulationsBELOTECA INC·Filed 2022·Application pending·0 cites
- 1254US6136850AMethods and compositions for inhibiting deposit formation on contact lensesALLERGAN INC·Filed 1993·Granted Oct 24, 2000·17 cites·18 claims
- 1353US2023338277A1Cetrorelix injectable liquid formulationBELOTECA INC·Filed 2023·Application pending·0 cites
- 1443US2022304893A1Protection of oxygen sensitive compoundsBELOTECA INC·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →